Norah A Terrault Selected Research

hepatitis B hyperimmune globulin

7/2020	Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B.
1/2017	Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
5/2012	The option of HBIG-free prophylaxis against recurrent HBV.
4/2008	Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
11/2007	Management of hepatitis B in liver transplant recipients.
5/2006	Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation.
1/2006	Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Norah A Terrault Research Topics

Disease

57	Infections 01/2021 - 10/2002
48	Fibrosis (Cirrhosis) 12/2022 - 03/2003
36	Hepatitis C 11/2019 - 03/2004
26	Liver Diseases (Liver Disease) 01/2022 - 07/2003
19	Hepatitis B 01/2022 - 10/2002
18	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 08/2006
15	Chronic Hepatitis B 01/2022 - 09/2004
15	End Stage Liver Disease 01/2020 - 01/2005
14	Hepatitis 01/2022 - 08/2004
10	Chronic Hepatitis C 11/2018 - 08/2005
9	Non-alcoholic Fatty Liver Disease 12/2022 - 02/2005
8	Reinfection 01/2017 - 10/2005
6	Viremia 01/2021 - 08/2006
6	Alcoholic Hepatitis 03/2020 - 01/2018
5	Neoplasms (Cancer) 01/2021 - 12/2002
5	HIV Infections (HIV Infection) 01/2021 - 10/2003
4	Obesity 10/2021 - 11/2015
4	Coinfection 01/2020 - 08/2004
4	Disease Progression 04/2016 - 10/2005
3	Weight Loss (Weight Reduction) 10/2021 - 01/2019
3	Thrombosis (Thrombus) 09/2020 - 12/2014
3	Inflammation (Inflammations) 01/2019 - 06/2015
3	Anemia 12/2014 - 08/2006
2	Fatty Liver 01/2022 - 02/2005
2	Intrahepatic Cholestasis of Pregnancy 01/2022 - 11/2020
2	Alcoholism (Alcohol Abuse) 01/2021 - 03/2020
2	Hemorrhage 09/2020 - 01/2020
2	Thrombocytopenia (Thrombopenia) 01/2020 - 12/2014
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020 - 11/2019
2	Persistent Infection 01/2020 - 04/2015
2	Hyperlipidemias (Hyperlipidemia) 11/2019 - 02/2005
2	Insulin Resistance 01/2019 - 11/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 06/2010
2	Hypertension (High Blood Pressure) 11/2015 - 08/2006
2	Opportunistic Infections (Opportunistic Infection) 09/2013 - 07/2003
2	Body Weight (Weight, Body) 04/2010 - 08/2006
1	Hemolysis 01/2022
1	Acute fatty liver of pregnancy 01/2022
1	HELLP Syndrome 01/2022
1	Acute-On-Chronic Liver Failure 01/2022
1	Hyperemesis Gravidarum 01/2022
1	Pre-Eclampsia (Preeclampsia) 01/2022
1	Lung Diseases (Lung Disease) 11/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021

Drug/Important Bio-Agent (IBA)

36	Antiviral Agents (Antivirals)IBA 11/2021 - 08/2004
17	Ribavirin (Virazole)FDA LinkGeneric 11/2018 - 08/2006
12	InterferonsIBA 01/2022 - 12/2004
11	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2003
9	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 05/2006
9	SofosbuvirIBA 01/2021 - 01/2015
9	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2004
8	Hepatitis B e AntigensIBA 01/2022 - 11/2015
8	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 08/2003
8	Alanine Transaminase (SGPT)IBA 01/2020 - 08/2006
8	Pharmaceutical PreparationsIBA 01/2020 - 08/2006
8	Lamivudine (Epivir)FDA Link 09/2009 - 10/2002
7	hepatitis B hyperimmune globulinIBA 07/2020 - 01/2006
5	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2022 - 08/2004
5	BilirubinIBA 01/2020 - 12/2016
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2015
4	AlbuminsIBA 01/2020 - 08/2015
4	AntigensIBA 11/2019 - 12/2004
4	peginterferon alfa-2a (Pegasys)FDA Link 01/2019 - 08/2006
4	Tenofovir (Viread)FDA Link 01/2019 - 12/2004
4	SodiumIBA 01/2018 - 01/2005
4	Protease Inhibitors (Protease Inhibitor)IBA 08/2015 - 10/2013
4	adefovirIBA 05/2009 - 12/2004
3	EnzymesIBA 01/2022 - 12/2004
3	ledipasvirIBA 11/2018 - 09/2015
3	sofosbuvir drug combination ledipasvirIBA 01/2018 - 09/2015
3	telaprevirIBA 08/2015 - 04/2010
3	Interferon-alpha (Interferon Alfa)IBA 01/2015 - 09/2004
2	nasIBA 01/2022 - 01/2022
2	Oral ContraceptivesIBA 01/2021 - 01/2017
2	Hormones (Hormone)IBA 01/2021 - 01/2017
2	Thrombopoietin ReceptorsIBA 09/2020 - 12/2014
2	VaccinesIBA 07/2020 - 01/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2020 - 01/2018
2	avatrombopagIBA 01/2020 - 12/2014
2	NucleosidesIBA 01/2019 - 09/2004
2	entecavir FDA Link 01/2019 - 01/2019
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2018 - 01/2005
2	NucleotidesIBA 09/2015 - 01/2015
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 08/2015 - 09/2014
2	adefovir dipivoxil (Hepsera)FDA Link 09/2009 - 09/2004
1	Estrogens (Estrogen)FDA Link 01/2021

Therapy/Procedure

80	Liver Transplantation 01/2022 - 10/2002
49	Therapeutics 01/2022 - 08/2004
25	Transplantation 01/2022 - 12/2002
4	Contraindications 01/2021 - 03/2003
3	Kidney Transplantation 01/2021 - 01/2019
2	Gastrectomy 10/2021 - 01/2019
2	Platelet Transfusion (Blood Platelet Transfusions) 09/2020 - 01/2020
2	Investigational Therapies (Experimental Therapy) 01/2020 - 11/2019
2	Donor Selection 01/2020 - 06/2010
2	Organ Transplantation 11/2019 - 09/2013
2	Aftercare (After-Treatment) 12/2016 - 05/2014
2	Highly Active Antiretroviral Therapy (HAART) 08/2004 - 07/2003
1	Hysterectomy 01/2021
1	Ovariectomy (Oophorectomy) 01/2021